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Summary 
Regulation of cerebral blood flow (CBF) is crucial for maintenance of oxygen and nutrient supply 
to the brain to assure proper function. One of the major regulators of CBF is partial pressure of 
arterial CO2 (PaCO2). CBF is attenuated with age both at rest and during exercise and 
concomitantly an age-associated reduction in PaCO2 has been demonstrated which may partly 
contribute to the decline in CBF with aging. Additionally, cerebrovascular reactivity to CO2 has 
been reported to be decreased with advancing age and thus may contribute to age-related reduction 
in CBF. As with advancing age, high altitude exposure challenges cerebral perfusion and has also 
been reported to affect cerebrovascular reactivity to CO2, however, outcomes are inconsistent.  
The purpose of the present PhD project was twofold. 1) To elucidate the role of CO2 on the 
regulation of cerebral blood flow during exercise with aging. To better understand alterations in 
CBF with aging during exercise, cerebrovascular reactivity to CO2 was assessed in young and 
elderly humans and CO2 was added to inspiration during exercise in combination with CBF 
determination. 2) To investigate the influence of high altitude on cerebrovascular reactivity to CO2. 
For this purpose cerebrovascular reactivity to CO2 was assessed in young and healthy volunteers 
during acute exposure and acclimatization to high altitude in a controlled setting. 
The two independent studies included in the present PhD thesis revealed the following: 1) 
Supplemental CO2 reduced the age-associated decline in middle cerebral artery mean velocity by 
50 %, suggesting that partial pressure of arterial CO2 is a major component in the age-related 
reduction in cerebral blood flow during exercise. 2) In response to high altitude acclimatization 
cerebrovascular reactivity to CO2 is increased, which may serve to maintain precise regulation of 
CBF in this environment. 
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Zusammenfassung 
Um die Sauerstoff- und Nährstoffversorgung des Gehirns, und damit dessen einwandfreie Funktion 
zu gewährleisten, ist eine funktionierende Regulation der Hirndurchblutung unerlässlich. Einer der 
wichtigsten Regulatoren der Hirndurchblutung ist der arterielle Partialdruck von CO2 (PaCO2). Mit 
zunehmendem Alter sinkt die Hirndurchblutung in Ruhe und während Belastung. Gleichzeitig 
wurde ein erniedrigter PaCO2 im Alter nachgewiesen, welcher zumindest teilweise der Grund für 
die altersabhängige Reduktion der Hirndurchblutung darstellen könnte. Zusätzlich wurde eine 
Abnahme der Reaktivität der Hirngefässe auf CO2 gemessen, welche daher als weitere mögliche 
Ursache für die altersbedingte Abnahme der Hirndurchblutung gehandelt werden kann. Ähnlich 
wie bei zunehmendem Alter stellt der Aufenthalt in der Höhe eine Herausforderung für die 
Regulation der Hirndurchblutung dar. Eine veränderte Reaktivität der Hirngefässe auf CO2 wurde 
zwar dokumentiert, jedoch wiedersprechen sich die Ergebnisse.  
Das vorliegende Dissertationsprojekt beinhaltet folgende zwei grundlegende Zielsetzungen: 1) Das 
Erläutern der Rolle von CO2 in der Regulation der Hirndurchblutung während körperlicher 
Belastung im Alter. Um die Änderungen der Hirndurchblutung im Alter besser zu verstehen, wurde 
während körperlicher Belastung CO2 zur Einatmungsluft hinzugefügt und gleichzeitig die 
Hirndurchblutung gemessen. 2) Das Untersuchen des Einflusses der Höhe auf die Reaktivität der 
Hirngefässe auf CO2. Dafür wurde die Reaktivität der Hirngefässe auf CO2 in jungen gesunden 
Studienteilnehmern während akuter und chronischer Höhenexposition mit kontrollierten 
Rahmenbedingungen bestimmt.  
Folgende Ergebnisse stammen aus den zwei unabhängigen Studien, welche das vorliegende 
Dissertationsprojekt beinhaltet: 1) Die Zugabe von CO2 führte zu einer 50 % Verminderung der 
altersbedingten Reduktion der Geschwindigkeit der mittleren Hirnarterie während Belastung. Dies 
unterstreicht den Einfluss von PaCO2 auf die altersabhängige Reduktion der Hirndurchblutung. 2) 
Höhenakklimatisation führte zu einer erhöhten Reaktivität der Hirngefässe auf CO2 und könnte so 
eine präzise Regulation der Hirndurchblutung in der Höhe fördern.  
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1. Introduction 
Regulation of cerebral blood flow  
The human brain accounts for merely ~ 2 % of the body weight,  however receives ~ 15 % of the 
total cardiac output and utilizes ~ 20 % of the oxygen taken up by the human organism at rest 
(Lassen 1959). Together with its limited capacity for substrate storage (Brown and Ransom 2007) 
this underlines the high energy demand of the brain. Hence, a precise regulation of cerebral blood 
flow (CBF) is crucial for maintenance of constant nutrient and oxygen supply to the brain.  
Arterial blood supply to the brain is shared between two pairs of large arteries, the right and left 
internal carotid and vertebral arteries. The vertebral arteries join distally to form the basilar arteries 
and branches from the vertebral and basilar artery supply the cerebellum and the brainstem. 
Additionally, the basilar artery joins the two internal carotid arteries to form the circle of Willis 
which is the origin of the three main intracerebral arteries; the anterior, middle, and posterior. 
These arteries then progressively divide into smaller arteries, arterioles and capillaries. Pial arteries 
run along the surface of the brain, arterioles enter the brain tissue and capillaries finally supply 
blood to the corresponding regions (Cipolla 2009). In this PhD project middle cerebral artery mean 
velocity (MCAvmean) was assessed using transcranial Doppler ultrasound (TCD) as a surrogate for 
CBF.  
Substantial reductions in CBF quickly lead to unconsciousness and if maintained, brain damage 
and death occur (Van Lieshout et al. 2003). Likewise, severe elevations in cerebral perfusion 
pressure may result in hemorrhage, breakthrough edema and stroke (Pires et al. 2013).   
Meticulous control of CBF involves a wide range of regulatory mechanisms that together work to 
ensure optimal oxygen and nutrient delivery (Willie et al. 2014). Principal regulators of CBF are 
partial pressure of arterial CO2 (PaCO2, (Ide et al. 2003), mean arterial pressure (MAP, Lucas et al. 
2010), cerebral metabolism (Belanger et al. 2011) and the autonomic nervous system (Hamner et 
al. 2010).  
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Even minor reductions in oxygen supply to the brain, as induced during strenuous exercise or 
exercise at high altitude, have been demonstrated to result in reduced exercise performance due to 
failure in neural drive from the motor cortex (Goodall et al. 2012). Additionally, chronic cerebral 
hypoperfusion, e.g. associated with aging, has been associated with cognitive impairment (Bertsch 
et al. 2009).  
In the present PhD thesis the focus will be on CO2 as it is one of the major regulators of CBF. The 
aim is to elucidate the role of CO2 during exercise with aging as well as the influence of high 
altitude on the cerebrovasculature by assessing cerebrovascular reactivity to CO2. 
Cerebral blood flow and CO2 
Half a century ago, low and high tensions of CO2 were demonstrated to affect the 
cerebrovasculature (Kety and Schmidt 1948). Since then, CO2 has been accepted to be one of the 
major regulators of CBF. Elevations in PaCO2 (hypercapnia) lead to vasodilation (Figure 1), 
whereas decreases in PaCO2 (hypocapnia) facilitate vasoconstriction of the cerebrovasculature (Ide 
et al. 2003). CBF increases by approximately 3 - 5 % and 2 - 3 % per increase and decrease from 
the resting value in mmHg of CO2, respectively (Poulin et al. 1996; Ide et al. 2003; Willie et al. 
2012).  
 
 
 
 
 
 
 
Figure 1. Middle cerebral artery velocity (MCAV) in response to 
changes in end-tidal partial pressure of CO2 (PetCO2). (Modified 
from (Poulin et al. 1996)). 
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These sensitivities are unique to the cerebrovasculature compared with the peripheral vasculature 
(Ainslie et al. 2005) and are also used as a measure of cerebrovascular function (Willie et al. 2011), 
called cerebrovascular reactivity to CO2 (CVR). Additionally, the CO2 induced vasodilation and 
vasoconstriction are involved in a homeostatic function by either removing CO2 from the cerebral 
tissue and thus increasing pH or restraining CO2 in the cerebral tissue leading to a reduction in pH, 
respectively (Chesler 2003). 
Although the effects of CO2 on the cerebral vessels have been assessed for decades, the underlying 
mechanisms leading to the changes in CBF are not fully elucidated. It is debated whether PaCO2, 
pH, or both are responsible for the changes in CBF. Inducing changes in pH while keeping PaCO2 
maintained did not lead to alterations in CBF (Harper and Bell 1963; Berne et al. 1981). A few 
years later, Kontos et al. (Kontos et al. 1977) demonstrated the importance of extracellular pH in 
the vasoactivity of cerebral vessels. Vasodilation and vasoconstriction in response to a reduction 
and elevation in extracellular pH, respectively, have been observed in cultured cerebral vascular 
muscle cells (Apkon et al. 1997). Furthermore, the mechanism causing a dilation in response to 
hypercapnia likely involves nitric oxide (Iadecola 1992). 
In the present studies CO2 is used to manipulate CBF to investigate the role of CO2 in the 
regulation of CBF during exercise with aging as well as to assess cerebrovascular function in 
young and older healthy volunteers and in response to high altitude.  
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1.1 Age, aerobic fitness and cerebral perfusion during exercise: Role of carbon 
dioxide 
Cerebral blood flow and exercise with age 
During exercise CBF increases with increasing exercise intensity until approximately 60 % of 
maximal oxygen uptake (VO2max) and thereafter declines towards resting levels (Hellström et al. 
1996; Fisher et al. 2008; Fisher et al. 2012; Marsden et al. 2012). The regulation of CBF during 
exercise is complex and underlies an integrative regulation. Elevated cerebral metabolism, blood 
pressure, cardiac output and PaCO2 possibly play a role in the elevation in CBF in response to 
exercise (Querido and Sheel 2007; Ogoh and Ainslie 2009). The decrease in cerebral perfusion 
during high exercise intensities is likely the consequence of a hyperventilation induced reduction in 
PaCO2 and thus leading to a vasoconstriction. This indicates CBF being mainly regulated by 
PaCO2 as CBF decreases despite further elevations in exercise intensity and cerebral metabolism 
(Ogoh and Ainslie 2009). Furthermore, adding CO2 to inspiration and thus counteracting the drop 
in PaCO2 abolishes the decline in CBF observed at higher exercise intensities (Olin et al. 2011; 
Siebenmann et al. 2013). The gradual decline in CBF with exercise intensity above a certain 
threshold also reduces cerebral oxygenation. This has been speculated to lead to centrally mediated 
fatigue and thus may limit exercise performance (Nielsen et al. 1999; Goodall et al. 2012). 
With healthy aging, CBF at rest, independent of the applied method to determine CBF, is reduced 
compared with young and healthy individuals (Kety 1956; Melamed et al. 1980; Ainslie et al. 
2008; Demirkaya et al. 2008; Galvin et al. 2010; Fisher et al. 2012; Liu et al. 2012; Murrell et al. 
2012; Zhu et al. 2013). During exercise CBF follows the above described pattern, however, in 
comparison with young volunteers CBF is reduced with increasing age (Fisher et al. 2012). 
Additionally, CVR has been reported to be decreased in older individuals (Bakker et al. 2004; 
Flück et al. 2014) and may contribute to the age-associated reduction in CBF. Yet, controversial 
data exists (Galvin et al. 2010; Zhu et al. 2013). Generally, the physiological mechanisms leading 
to a decline in CBF with aging remain uncertain. Possible mechanisms for the age-related decrease 
in CBF include increased arterial stiffness (Zhu et al. 2011; Flück et al. 2014) and global brain 
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atrophy (Fjell et al. 2009), although the latter has been argued not to contribute to the age-related 
decline in CBF (Chen et al. 2011). Additionally, the concomitantly occurring and age-dependent 
decrease in PaCO2 at rest (Fisher et al. 2012) and during exercise (Fisher et al. 2012; Marsden et al. 
2012) may be involved in the age-associated reduction in cerebral perfusion (Figure 2). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Cerebral blood flow and aerobic fitness 
Beneficial effects of an increased aerobic fitness on the cerebrovasculature have been demonstrated 
(Ainslie et al. 2008; Bailey et al. 2013; Thomas et al. 2013), however, this has not been universally 
observed (Barnes et al. 2013; Zhu et al. 2013). The influence of aerobic fitness was expressed by 
the association of resting CBF or CVR with VO2max. Ainslie et al. (Ainslie et al. 2008) observed 
an elevated resting CBF in active vs. sedentary individuals over a wide age range while 
Figure 2. Middle cerebral artery mean velocity 
(MCAvmean, A) and arterial partial pressure of 
CO2 (PaCO2, B) at rest and during exercise in 
young and older individuals. (Modified from 
(Fisher et al. 2012)). 
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contradictory results derive from studies with a study cohort with a narrow age range (Barnes et al. 
2013; Zhu et al. 2013). CVR has been reported to be increased after a 12-week exercise training 
(Murrell et al. 2012). On the other hand, compared with sedentary elderly, hypercapnic CVR was 
not elevated in master athletes (Zhu et al. 2013).  
Study aim 
The aims of the first study included in the present PhD thesis were: 1) to determine the effect of 
age on hypercapnic CVR compared with healthy young individuals, 2) to establish the importance 
of the age-related drop in PaCO2 on MCAvmean by administering supplemental CO2 to inspiration 
during exercise, 3) to examine the effects of aerobic fitness on hypercapnic CVR and the age-
related decrease in MCAvmean by comparing aged and young individuals that are aerobically 
trained or untrained and 4) to investigate whether maintaining MCAvmean and thereby cerebral 
oxygenation would lead to an improvement in exercise capacity in young and older individuals. 
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1.2 Cerebrovascular reactivity increases with acclimatization to 3454 m 
Cerebral blood flow and high altitude 
High altitude exposure leads to a decrease in arterial partial pressure of O2 (PaO2) and PaCO2. In 
comparison to PaCO2, the cerebrovasculature is less sensitive to changes in PaO2, with 
vasodilation only occurring when PaO2 declines below ~ 60 mmHg (Gupta et al. 1997). With acute 
exposure to high altitude, the hypoxic vasodilatory effect facilitates an elevation in CBF. However 
with acclimatization to altitude this is counteracted by the hypoxic ventilatory response which 
causes a further reduction in PaCO2 and thus CBF declines towards sea-level values (Severinghaus 
et al. 1966; Møller et al. 2002). CVR may intuitively be expected to be decreased in response to the 
ventilatory induced reduction in PaCO2 in order to preserve CBF. Yet, several studies have 
assessed CVR in response to hypoxic exposure (Jensen et al. 1996; Jansen et al. 1999; Poulin et al. 
2002; Ainslie and Burgess 2008; Fan et al. 2010; Lucas et al. 2011; Villien et al. 2013; Fan et al. 
2014; Ogoh et al. 2014; Rupp et al. 2014) and the outcomes are highly controversial, ranging from 
increased (Jensen et al. 1996; Poulin et al. 2002; Fan et al. 2010; Fan et al. 2014), unchanged 
(Jansen et al. 1999; Villien et al. 2013; Rupp et al. 2014) to reduced (Ainslie and Burgess 2008; 
Lucas et al. 2011; Ogoh et al. 2014) CVR (Figure 3 and 4). These differences possibly derive in 
part from inconsistencies in study protocols and methods applied. Briefly, the CVR tests have been 
conducted in different background oxygen levels (Fan et al. 2014;Rupp et al. 2014;Villien et al. 
2013), at varying time points of altitude exposure (Lucas et al. 2011) and, additionally, only a few 
studies have taken changes in blood pressure into account when assessing CVR (Fan et al. 2014). 
Furthermore, most studies have been conducted under conditions similar to a mountain expedition 
(Jansen et al. 1999; Ainslie and Burgess 2008; Fan et al. 2010; Lucas et al. 2011) including a 
trekking ascent over several days, board and lodging, which contrast markedly with subject’s usual 
environment and habits, all being potential confounding factors. 
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Figure 3. Individual middle cerebral artery 
velocity (MCAvmean) responses during 
hypercapnia at sea level and after 2-4, 7-9 and 
12-15 days at high altitude.* P<0.05 compared to 
sea level. (Modified from (Lucas et al. 2011)). 
Figure 4. Changes in steady-state estimates of 
cerebrovascular responsiveness to CO2 at sea 
level (SL), 1 (ALT1) and 16 (ALT16) days and 
after 7 (POST7) and 21 (POST21) days of 
reexposure to 5260 m. * P<0.05 compared to 
SL. † P<0.05 compared to ALT1. § P<0.05 
compared to ALT16. (Modified from (Fan et al. 
2014)). 
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Study aim 
The aim of the second study included in the present PhD thesis was to overcome the above 
mentioned limitations by performing a study at the Jungfraujoch research station (3454 m) where 
living conditions are comparable to subject’s daily life and allow for measurements immediately 
after a two hour train ascent. Additionally, hypo- and hypercapnic CVR were assessed in 
background hypoxia and normoxia at sea level and then again after exactly 30 min, 3 and 22 days 
of hypoxic exposure.  
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2. Methods
The methods used in the studies included in the present PhD thesis will be briefly introduced, 
however in detail information can be found in the published manuscripts. 
2.1 Cerebral blood flow 
In 1945, Kety and Schmidt modified the inert gas method, previously used to measure cardiac 
output, to also determine CBF. The method is based on the Fick principle (Fick 1870), where flow 
can be determined as the ratio between the uptake of an inert gas per unit time and the arterio-
venous inert gas difference across the organ. Kety and Schmidt have used the inert gas nitrous 
oxide to determine CBF which was introduced to the arterial blood via the lungs (Kety and Schmidt 
1948), but also other freely diffusible tracers have been used (e.g. Xenon, Hydrogen). This method 
is considered the gold standard in research, however it also encompasses limitations. Briefly, the 
measurement is time consuming and does not allow to observe dynamic changes in CBF, it is also 
very invasive and it assesses only a global measure of CBF (Willie et al. 2011). 
The introduction of Transcranial Doppler Ultrasound (TCD) brought the advantage of assessing 
dynamic changes in CBF as it has a high temporal resolution, in addition to being a non-invasive 
and a rather inexpensive method (Aaslid et al. 1982). Through the temporal window, where the 
skull is thin and thus insonation of the three large intracranial arteries are possible, a pulse of 
ultrasound is transmitted using an ultrasound probe. The emitted ultrasound is scattered by the 
moving erythrocytes and the frequency shift (Doppler shift) of the detected ultrasound signal by the 
receiver is proportional to the velocity of the blood. It has to be considered though that TCD 
assesses velocity and not flow in absolute terms, as the vessel diameter of the insonated artery 
remains unknown. In order to asses CBF by using TCD an unchanged vessel diameter is assumed 
(Aaslid et al. 1982). Several studies have demonstrated a constant vessel diameter (Poulin and 
Robbins 1996; Serrador et al. 2000; Verbree et al. 2014), however, recently small changes in vessel 
diameter have been observed in response to extreme increases in PaCO2 or decreases in PaO2 
(Wilson et al. 2011; Willie et al. 2012; Verbree et al. 2014). Consequently, when using TCD to 
assess MCAvmean limitations have to be discussed. Nevertheless, the assessment of blood velocity 
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using TCD has been accepted as a reliable measure of CBF. Its small size and fixation to a 
headband enables continuous measuring during experimental protocols such as cycling (Willie et 
al. 2011).  
For the studies included in this PhD thesis the MCA was insonated using a 2 MHz probe (Doppler 
Box, DWL, Sipplingen, Germany). MCAvmean was assessed continuously through the experiments 
with the ultrasound probe held in place with a headgear. 
2.2 Inspired gas manipulations and respiratory parameters 
By wearing a mask, covering nose and mouth, or breathing through a mouthpiece with the nose 
occluded, respiratory parameters were assessed breath by breath (Cosmed Quark b2, Rome, Italy).  
In order to manipulate partial pressure of end tidal CO2 (PetCO2) and O2 (PetO2), CO2 was added 
to inspiration and ambient air was diluted with nitrogen or O2 via a mixing chamber (Altitrainer, 
SMTEC, Nyon, Switzerland). Continuous recording of breath by breath respiratory parameters 
enabled an accurate control of desired CO2 or O2 levels. A reduction in PetCO2 was achieved 
through voluntary hyperventilation by the study participants. In the first study included in the 
present PhD project, resting PaCO2 and PaCO2 during the hypercapnic CVR test were estimated 
from PetCO2 using the Peebles’ calculation (Peebles et al. 2007). During exercise PaCO2 was 
estimated using the Jones’ equation (Jones et al. 1979). 
2.3 Cerebrovascular reactivity to CO2 
Combining the two above mentioned methods enables the assessment of CVR. As mentioned 
before, CO2 is a major regulator of CBF and therefore CVR assesses the ability of the 
cerebrovasculature to react to changes in PetCO2. The reactivity of the cerebrovasculature also 
serves as a surrogate of cerebrovascular function (Willie et al. 2011). In the following studies, we 
have used step protocols to elevate PetCO2 and voluntary hyperventilation to induce a reduction in 
PetCO2. Simultaneously, MCAvmean was measured and reactivity was calculated as either an 
absolute or a relative change in MCAvmean per increase in PetCO2. Due to the known effects of 
MAP on CBF as well as changes in MAP induced by alterations in PetCO2 (Claassen et al. 2007; 
Ainslie and Duffin 2009), it is important to concomitantly measure MAP. MAP was recorded 
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continuously and noninvasively via finger photopletysmography (Nexfin, BMEYE B.V, 
Amsterdam, Netherlands). Moreover cerebrovascular conductance (CVC) can be calculated 
(MCAvmean / MAP) as well as CVC CVR to take changes in MAP into account (Claassen et al. 
2007; Regan et al. 2014). 
2.4 Exercise testing 
In order to determine study volunteer’s maximal workload (Wmax) and VO2max an incremental 
exercise test on a cycle ergometer was performed (Monark E 839, Vaarberg, Sweden). According 
to the study participants achieved Wmax an individualized exercise protocol consisting of two 
absolute workloads (60, 100 W) and four relative workloads (25, 50, 75, 100 % Wmax) was 
generated. This allowed for comparison at the same absolute and relative workloads. 
2.5 Cerebral and muscle oxygenation 
Near infrared spectroscopy (NIRS; Invos-5100c, Covidien, Mansfield, MA) was used to assess 
cerebral and muscle tissue oxygenation. NIR light is emitted into the tissue, during its penetration 
through the tissue, before reaching the detector, NIR light is absorbed and scattered. According to 
the changes of light intensity from its emission to its detection an index for tissue oxygenation 
derives (Boushel et al. 2001). NIRS sensors were placed on the forehead and the vastus lateralis 
muscle to assess cerebral and muscle tissue oxygenation, respectively. 
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3. Manuscripts 
3.1 Age, aerobic fitness and cerebral perfusion during exercise: role of carbon dioxide 
3.2 Cerebrovascular reactivity increases with acclimatization to 3454 m 
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Flück D, Braz ID, Keiser S, Hüppin F, Haider T, Hilty MP,
Fisher JP, Lundby C. Age, aerobic ﬁtness, and cerebral perfusion
during exercise: role of carbon dioxide. Am J Physiol Heart Circ
Physiol 307: H515–H523, 2014. First published June 20, 2014;
doi:10.1152/ajpheart.00177.2014.—Middle cerebral artery mean ve-
locity (MCAvmean) is attenuated with increasing age both at rest and
during exercise. The aim of this study was to determine the inﬂuence
of the age-dependent reduction in arterial PCO2 (PaCO2) and physical
ﬁtness herein. We administered supplemental CO2 (CO2 trial) or no
additional gas (control trial) to the inspired air in a blinded and
randomized manner, and assessed middle cerebral artery mean ﬂow
velocity during graded exercise in 1) 21 young [Y; age 24  3 yr
(SD)] volunteers of whom 11 were trained (YT) and 10 considered
untrained (YUT), and 2) 17 old (O; 66  4 yr) volunteers of whom 8
and 9 were considered trained (OT) and untrained (OUT), respectively.
A resting hypercapnic reactivity test was also performed. MCAvmean
and PaCO2 were lower in O [44.9  3.1 cm/s and 30  1 mmHg
(SE)] compared with Y (59.3  2.3 cm/s and 34  1 mmHg, P 
0.01) at rest, independent of aerobic ﬁtness level. The age-related
decreases in MCAvmean and PaCO2 persisted during exercise. Sup-
plemental CO2 reduced the age-associated decline in MCAvmean by
50%, suggesting that PaCO2 is a major component in the decline. On
the other hand, relative hypercapnic reactivity was neither inﬂuenced
by age (P  0.46) nor aerobic ﬁtness (P  0.36). Although supple-
mental CO2 attenuated exercise-induced reduction in cerebral oxy-
genation (near-infrared spectroscopy), this did not inﬂuence exercise
performance. In conclusion, PaCO2 contributes to the age-associated
decline in MCAvmean at rest and during exercise; however exercise
capacity did not diminish this age effect.
brain blood ﬂow; middle cerebral artery; old; transcranial Doppler
CEREBRAL BLOOD FLOW (CBF) is meticulously regulated to en-
sure an adequate perfusion of the brain. With exercise middle
cerebral artery mean velocity (MCAvmean; a surrogate measure
of CBF) is increased until 60% of maximal oxygen uptake
(V˙ O2max) but thereafter declines toward resting levels (10, 20,
28). In young healthy individuals this drop in cerebral perfu-
sion is likely the consequence of a hyperventilation facilitated
reduction in PaCO2 and hence augmented cerebral vasocon-
striction (39). Accordingly, administration of CO2 to the in-
spired air during exercise abolishes the decrease in MCAvmean
(44, 45), and during vigorous exercise MCAvmean is regulated
by PaCO2 and only to a lesser extent inﬂuenced by cerebral
metabolism, mean arterial pressure (MAP), cardiac output, or
sympathetic nerve activity (35).
Compared with young healthy individuals a reduced CBF
(24) and MCAvmean has consistently been reported in the aged
population both at rest (2, 7, 9, 15, 25, 27, 49) and during
exercise (9, 10, 28, 32). Although a reduced MCAvmean re-
sponse in aged humans is observed with exercise, its pattern
follows that of young individuals, i.e., an initial increase which
is then followed by a decline as the exercise intensity becomes
intense (9, 10, 28, 32). The regulating mechanisms for the
reduction in CBF with age remain uncertain and global brain
atrophy (11), decreased neuronal activity (29), increased arte-
rial stiffness (12, 50), and reduced cerebrovascular reactivity
(12, 22) have all been proposed as important factors. In
addition, the concomitantly occurring and age-dependent de-
crease in PaCO2 at rest (9) and during exercise (9, 28) may be
involved in the age-associated reduction in cerebral perfusion.
This however has not been tested experimentally, and is one
aim of the present study. An age-related reduction in CO2
reactivity could also diminish the CBF response to exercise.
The effect of aging on CO2 reactivity is not clear, however, as
hypercapnic reactivity has been demonstrated to be either
unchanged (15, 24, 42), reduced (4, 22, 48), or even elevated
(49) with increasing age. One reason for the discrepancies
could be related to the use of humans over a narrow age range,
and with varying degrees of physical ﬁtness. Thus a further aim
related to this study was to quantify CO2 reactivity and to
investigate its association to the decrease in MCAvmean with
age.
A high aerobic ﬁtness level appears to attenuate the age-
related decline in resting CBF (39) and MCAvmean (1–3, 46),
although this has not been universally observed (4, 49).
Whether ﬁtness is a factor affecting CBF during exercise
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remains unclear. Moreover, aerobic ﬁtness may affect hyper-
capnic cerebrovascular reactivity (4, 32, 49), although these
ﬁndings are also contradictory as increased (3, 32), unchanged
(49) and decreased (46) hypercapnic reactivity has been re-
ported in aerobically trained individuals. Again potential inﬂu-
encing factors for the widespread results could include differ-
ences in age and ﬁtness levels across studies.
Accordingly the purpose of the present study was fourfold:
1) to determine the effect of age on hypercapnic reactivity
compared with healthy young individuals, 2) to establish the
importance of the age-related drop in PaCO2 on MCAvmean by
administering supplemental CO2 to the inspiration during ex-
ercise, 3) to examine the effects of physical ﬁtness on hyper-
capnic reactivity and the age-related decrease in MCAvmean by
comparing aged and young individuals that are aerobically
trained or untrained, and 4) to investigate whether maintaining
MCAvmean and thereby cerebral oxygenation would lead to an
improvement in exercise capacity in young and older individ-
uals. We hypothesized that supplementing the inspired air
with CO2 during exercise would reduce the age-related reduc-
tion in MCAvmean. Second, we hypothesized that elderly indi-
viduals with superior aerobic ﬁtness would possess a higher
MCAvmean than their untrained peers both at rest and during
exercise, and that this difference would also be accompanied
by a higher hypercapnic reactivity. Finally we expected that
improvements in MCAvmean elicited by CO2 supplementation
would not lead to an improved exercise capacity.
METHODS
All experimental protocols and procedures conformed to the Dec-
laration of Helsinki and were approved by the ethical committee of the
Swiss Federal Institute of Technology Zürich (EK 2013-N-17). Prior
to participation, a detailed verbal and written explanation of the study
was provided, and written informed consent to take part in this study
was obtained from each participant. Subjects were screened by means
of a general health questionnaire to identify any history or symptoms
of cardiovascular (e.g., hypertension), pulmonary, metabolic, or neu-
rological disease or use of medications. We recruited 21 young
(YTUT) males and 24 older (OTUT) males to participate in the
study. Based on an evaluation of their medical history and a physical
examination, as well as a 12-lead resting ECG assessing abnormality
of the heart, seven older subjects were excluded from participating in
the study. Consequently, 21 YTUT [24 3 yr (SD)] and 17 OTUT
(66  4 yr) completed the study. Subject groups were also divided
into trained (T) and untrained (UT) groups independent of the type of
training performed, ﬁrst by self-assessment and then conﬁrmed by
their achievement in the maximal incremental exercise test (43)
during their preliminary visit to the laboratory. Consequently 11
young trained (V˙ O2max: 65.6  1.0 ml·kg1·min1; YT), 10 young
untrained (49.6  1.8 ml·kg1·min1; YUT), 8 older trained (40.5 
2.5 ml·kg1·min1; OT), and 9 older untrained (29.6  1.3
ml·kg1·min1; OUT) individuals participated in the study (Table 1).
During a preliminary visit to the laboratory, subjects were famil-
iarized with the exercise tests and the study set-up. On the second visit
to the laboratory a hypercapnic reactivity test plus two maximal
incremental exercise tests were performed, one without and one with
additional CO2 to inspiration. Between subjects the tests were con-
ducted at different times of the day; however, within-subject compar-
ison data were assessed at the same time of the day. Subjects were
requested to abstain from strenuous physical activity for 24 h, and
alcohol and caffeine for 12 h prior to experimental sessions. Moni-
toring procedures associated with medical safety during exercise were
performed in real-time by a physician and included a 12-lead ECG,
oscillometric noninvasive blood pressure measurements with a 3 min
monitoring interval and a ST elevation check of I-aVF, V1-V6, in a
1-min interval. Termination criteria for the exercise test were systolic
blood pressure above 220 mmHg or a 10-mmHg drop below baseline,
ST anomalies, arrhythmias, and symptoms such as dizziness, syncope,
or cyanosis. Posttest monitoring was for 15 min if asymptomatic and
if BP and ECG reached baseline values. No test participants were
excluded on the basis the above investigations.
Experimental measures. MCAvmean was assessed using transcra-
nial Doppler ultrasonography (Doppler Box, DWL, Sipplingen, Ger-
many) with a 2 MHz probe placed over the right temporal window,
prepared with ultrasound gel. The probe was held in place with a
snug-ﬁtting headgear. Mean arterial pressure (MAP) was recorded
continuously and noninvasively via ﬁnger photoplethysmography
(Nexﬁn, BMEYE B.V, Amsterdam, Netherlands) and heart rate (HR)
was assessed by a monitor belt (Cosmed Quark b2, Rome, Italy).
MCAvmean and MAP were sampled at 1,000 Hz and stored for ofﬂine
analysis (LabChart 7 Pro v7.3.5 and Powerlab, ADInstruments, Bella
Vista, NSW, Australia).
Table 1. Age, weight, height, BMI, MAP, absolute and relative V˙ O2max, PaCO2, MCAvmean, and absolute, relative and CVC
CO2 reactivity at rest in young and older, trained and untrained individuals
Young Old P Value
Trained
(n  11)
Untrained
(n  10)
Trained
(n  8)
Untrained
(n  9) Age Training Interaction
Age, yr 22  0 25  1 65  0 67  1  0.01 0.06 0.78
Weight, kg 71.0  2.3 78.8  2.7 72.1  2.5 82.3  3.9 0.46  0.01 0.69
Height, m 1.82  0.02 1.81  0.02 1.72  0.01* 1.79  0.02  0.01 0.07 0.05
BMI, kg/m2 21.4  0.5 23.9  0.8 24.2  0.9 25.4  1.1 0.02 0.04 0.44
MAP, mmHg 91.3  1.8 92.3  1.8 92.0  3.4 94.  2.8 0.67 0.60 0.85
Wmax, W 388  16 318  12 238  10 216  17  0.01 0.01 0.13
Absolute V˙ O2max, l/min 4.66  0.14 3.88  0.12 2.90  0.16 2.42  0.12  0.01  0.01 0.32
Relative V˙ O2max, ml·min1· kg1 65.6  1.0 49.6  1.8 40.5  2.5 29.6  1.3  0.01  0.01 0.15
PaCO2, mmHg 34.8  0.5 32.8  0.9 30.4  0.8 29.4  0.9  0.01 0.07 0.56
MCAvmean, cm/s 56.1  2.7 62.9  3.3 49.7  4.9 40.6  2.8*  0.01 0.76 0.04
Absolute CO2 reactivity, cm·s1·mmHg1 1.99  0.37 1.57  0.26 1.95  0.36 1.82  0.21 0.73 0.38 0.64
Relative CO2 reactivity, %/mmHg 3.42  0.68 2.80  0.29 3.64  0.36 3.32  0.54 0.49 0.38 0.78
CVC CO2 reactivity, cm·s1·mmHg2 0.016  0.003 0.013  0.002 0.010  0.003 0.009  0.001 0.06 0.47 0.71
Values are means  SE. BMI, body mass index; MAP, mean arterial pressure; V˙ O2max, maximal oxygen uptake; PaCO2, estimated arterial partial pressure
of CO2; MCAvmean, middle cerebral artery mean velocity; CVC, cerebrovascular conductance. P values represent ANOVA results. *P  0.05 vs. young. Young
trained and untrained and older trained and untrained are compared at rest.
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By wearing a mask covering nose and mouth (Hans Rudolph)
respiratory variables were measured breath-by-breath using a spirom-
eter. A capillary blood sample was obtained from the right ear lobe at
BL, and during exercise at 100 W, at 75% maximal workload
(Wmax), and at exhaustion. Capillary PCO2 (PcapCO2), pH, and
HCO3 were measured using a blood gas analyzer (ABL800, Radi-
ometer, Copenhagen, Denmark). Cerebral and muscle tissue oxygen-
ation (cerebral and muscle StO2) were continuously assessed on the
left forehead and right vastus lateralis muscle, respectively, by near-
infrared spectroscopy (NIRS; Invos-5100c, Covidien, Mansﬁeld, MA).
Hypercapnic reactivity test. Hypercapnic reactivity test was per-
formed by adding CO2 to the inspired air (Altitrainer, SMTEC, Nyon,
Switzerland) with subjects in a semisupine position. After a 10-min
resting phase, PaCO2 (estimated from end-tidal PCO2) was recorded
for 3 min following which the CO2 reactivity test protocol was
undertaken. The protocol consisted of three steps of 120 s: step 1
(PaCO2  1.5 mmHg above resting values), step 2 (PaCO2  6.5
mmHg above resting values), and recovery (PaCO2  1.5 mmHg
above resting values). Maintaining PaCO2 at 1.5 mmHg above resting
values facilitates PaCO2 control (21) and reduces breath-to-breath
variability in cerebral blood ﬂow velocity (19).
Exercise test. During the preliminary visit to the laboratory each
subject performed a maximal incremental exercise test on a cycle
ergometer (Monark E 839, Varberg, Sweden) to determine their
Wmax and V˙ O2max using a protocol starting with a warm-up period of
5 min at 100 W (YT), 150 W (YT), 20 W (OUT), or 50 W (OT).
Thereafter the workload was increased every minute by 30 W (YT,
YUT and OT) or 20 W (OUT) until exhaustion.
On the second visit to the laboratory subjects completed two
incremental exercise tests in a blinded and randomized manner with-
out (control trial) and with supplemental inspired CO2 (CO2 trial). The
trials were separated by at least 90 min to limit any potential carryover
effect (41). The workload selected during the exercise protocol was
based on the Wmax achieved during the maximal incremental exer-
cise test performed on the ﬁrst visit. Both the control trial and the CO2
trial followed the same individualized protocol consisting of two
absolute workloads (60 W, 100 W) and four relative workloads (25%
Wmax, 50% Wmax, 75% Wmax, and 100% Wmax). The ﬁrst four
workloads were set to last 3 min each, the ﬁfth workload for 2 min,
and the ﬁnal workload (100% Wmax) was performed until exhaustion.
The duration that the subjects were able to sustain 100% Wmax was
used as a measure of exercise performance. This protocol design
allows comparison between groups at the same absolute and relative
exercise intensities. Prior to each exercise test a 2 min resting
measurement on the cycle ergometer (BL) was conducted. The control
trial was performed without the addition of supplemental inspired
CO2 whereas PaCO2 was continuously monitored in the CO2 trial and
when PaCO2 dropped below 40 mmHg CO2 was added to the inspired
air preventing the exercise-induced drop in PaCO2.
Data analysis and calculations. Data were recorded continuously.
Resting PaCO2 and PaCO2 during the hypercapnic reactivity test was
estimated from end-tidal PCO2 (PETCO2) by the equation (37):
estimated PaCO2 2.367 0.884 PETCO2
During the exercise tests PaCO2 was estimated from PETCO2 by the
equation (23):
estimated PaCO2 5.5 0.9 PETCO2 0.0021 VT
where tidal volume (VT) is in milliliters.
Resting MCAvmean, MAP, and PaCO2 were averaged over the last
minute of the resting phase prior to the hypercapnic reactivity test.
Baseline, absolute, and relative exercise intensity values represent an
average over 1 min whereas the “last 20 s” time point represents an
average of the last 20 s of each exercise trial. This was chosen to
reduce the chance of missing the changes in the measured parameters
at maximal exercise shortly before exhaustion. Cerebrovascular con-
ductance (CVC) was calculated as MCAvmean divided by MAP. CO2
reactivity was calculated as absolute and relative changes in
MCAvmean divided by the increase in PaCO2. Additionally CVC CO2
reactivity was calculated as CVC changes divided by the increase in PaCO2.
Statistics. Comparisons of resting values were made using a two-
way ANOVA with the main factors being age (young vs. old) and
training status (trained vs. untrained). For each the absolute and
relative exercise intensities a separate four-way ANOVA was used for
exercise variable comparisons, where the main factors were age,
training status, intensity (BL, 60 W, 100 W and BL, 25%, 50%, 75%,
100% Wmax, last 20 s) and condition (control vs. CO2 trial). Tukey’s
range test was applied for post hoc analysis. Statistical signiﬁcance
was set at P  0.05. Statistical analyses were performed using SAS
Enterprise Guide (4.3, SAS Institute, Cary, NC).
RESULTS
All 38 volunteers completed the study. Independent of the
participant’s physical ﬁtness level there was a main age effect
between the YTUT and the OTUT (Table 1). Brieﬂy, resting
MAP was similar in the two groups. PaCO2 and MCAvmean
were higher in YTUT compared with OTUT. Furthermore, an
interaction for MCAvmean between age and training was found
and post hoc analysis revealed an age difference within the
untrained groups.
Maximal workload and oxygen uptake with exercise. Wmax
achieved by YTUT was 35% higher (354  13 vs. 227  11
W, P  0.01) than in OTUT. Within the age groups, trained
participants reached 18% and 9% (YTUT and OTUT) higher
Wmax compared with the untrained participants (388  10 vs.
318  13 W, P  0.01, YT vs. YUT; 238  10 vs. 216  19
W, P  0.01, OT vs. OUT). Absolute and relative V˙ O2max are
presented in Table 1. V˙ O2, carbon dioxide production (V˙ CO2),
and respiratory exchange ratio (RER) are presented in Table 2.
Hypercapnic reactivity test. PaCO2 was increased (P 
0.01) from step 1 to step 2 in YTUT (38.1  0.5 to 42.2.0 
0.6 mmHg) and OTUT (34.5  0.7 to 38.5  0.7 mmHg).
Concomitantly MAP was augmented by 3.3 0.8 and 5.3 0.8
mmHg in YTUT and OTUT, respectively. Hypercapnic reactiv-
ity data (Table 1) are presented in absolute and relative MCAvmean
as well as absolute CVC changes to 1 mmHg increase in PaCO2.
Neither of these differed between the age groups and trained vs.
untrained study volunteers. CVC CO2 reactivity, however, tended
(P  0.06) to be slightly lower with age.
PaCO2, MCAvmean, MAP, and CVC in the control vs. the
CO2 exercise trial. Figure 1 illustrates PaCO2, MCAvmean,
MAP, and CVC data from the control and CO2 trial for YTUT
(YT and YUT pooled) and OTUT (OT and OUT pooled). In the
control trial, PaCO2 was elevated with increasing exercise
intensity until 75% Wmax and thereafter decreased in both
age groups. In accordance with the lower PaCO2 at BL, PaCO2
during exercise (control trial) was also lower (P  0.01) in
OTUT compared with YTUT. CO2 was administrated to
inspiration during exercise in the CO2 trial to keep PaCO2
above 40 mmHg (YTUT, 42.6  0.4 mmHg; OTUT, 45.2 
0.3 mmHg). Analysis of values at absolute exercise intensities
revealed an interaction of age, condition, and intensity (P 
0.01, Fig. 1A). Post hoc analysis demonstrated lower PaCO2
values in the control trial of the OTUT compared with OTUT
CO2 trial and YTUT control and CO2 trial at 60 and 100 W. A
main effect of age (P  0.01) and an interaction between
intensity and condition (P  0.01) was observed within the
relative exercise intensities data. At 75%, 100% Wmax and last
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20 s, PaCO2 was elevated in the CO2 trial compared with the
control trial in both age groups.
Figure 1B presents MCAvmean values during the control and
CO2 trial for both age groups. Throughout exercise MCAvmean
in the OTUT was lower compared with YTUT. MCAvmean
was higher at 100% Wmax and the last 20 s in the CO2 trial
compared with the control trial in YTUT and OTUT.
MAP responses to exercise are presented in Fig. 1C. Training
status did not show an effect on MAP response during absolute or
relative exercise intensities in both age groups (P  0.58). CVC
for the control and CO2 trial and both age groups is presented in
Fig. 1D. At absolute and relative exercise intensities a main effect
of age was apparent. In agreement with MCAvmean, CVC was
also increased at 100% Wmax and the last 20 s in the CO2 trial
compared with the control trial in both age groups.
Ventilation and exercise performance in the control vs. the
CO2 exercise trial. Ventilation (V˙ E) was elevated with increas-
ing exercise intensity (P  0.01); however, it was not different
between YTUT and OTUT at BL, 60 W, and 100 W (14.7 
0.6 vs. 14.6  0.7, 34.7  0.8 vs. 34.7  1.5 and 47.1  1.3
vs. 51.4  2.0 l/min, P  0.22). Analysis of V˙ E during relative
exercise intensities revealed an interaction between age and
intensity (P  0.01), and at 75% Wmax (96.8  3.1 vs. 73.8 
2.6 l/min), 100% Wmax (134.5  3.4 vs. 87.8  2.8 l/min),
and last 20 s (140.0  3.6 vs. 90.6  3.1 l/min) V˙ E was
elevated in YTUT vs. OTUT. A main effect of condition was
only apparent when absolute intensities [e.g., 100 W in OTUT:
48.9 2.4 vs. 53.9 3.2 l/min, control vs. CO2 trial (P 0.01)]
were evaluated, whereas there was no main effect of condition
when relative exercise intensities were assessed (P  0.52).
The duration at 100% Wmax was lower in the OTUT
compared with the YTUT (P  0.01), independent of their
ﬁtness level (P  0.49). Additionally both age groups sus-
tained a shorter duration at 100% Wmax during the CO2 trail
(YT, 106  11 s; YUT, 83  11 s; OT, 50  11 s; OUT, 48 
11 s) compared with the control trial (YT, 116  12 s; YUT,
85  11 s; OT, 61  10 s; OUT, 87  16 s; P  0.01).
Trained vs. untrained study volunteers. Figure 2 illustrates
the same data as in Fig. 1 except that age groups are divided
into a trained (YT and OT) and untrained group (YUT and OUT)
according to their V˙ O2max (Table 1). A main effect of training
status was not evident for MCAvmean, MAP, CVC, and V˙ E at
absolute or relative exercise intensities. PaCO2 during relative
exercise intensities, however, demonstrated a main effect of
training status. An interaction between intensity and training
status was observed, along with an interaction between condi-
tion and training status. PaCO2 values during the control trial
in both age groups were lower in the untrained vs. trained
volunteers. Training status did not exert an effect on PaCO2
when compared at absolute exercise intensities.
Relative changes in PaCO2, MCAvmean and CVC during control
and CO2 trial. Percent changes from baseline are similar to that
observed for the absolute values (Fig. 1) except that the magnitude of
the age-related difference in the MCAvmean and PaCO2 response to
exercise was diminished. The supplemental CO2 given to inspiration
resulted in a greater increase in CO2 in the OTUT comparedwith the
YTUT during exercise at the same absolute intensity.
Capillary blood samples. Due to an insufﬁcient volume of
blood being obtained from some of the participants these data
are derived from n  13 (8 YTUT and 5 OTUT). PcapCO2
values are in agreement with the estimated PaCO2 values from
the spirometer (r 0.76, P 0.01). Baseline pH did not differ
between YTUT (7.40  0.01) and OTUT (7.41  0.01, P 
0.80). At exhaustion pH in the YTUT was 7.27  0.02 and
7.27  0.02 for control and CO2 trial, respectively, and in
OTUT pH was 7.34  0.01 and 7.33  0.01. A main effect of
Table 2. Oxygen uptake, carbon dioxide production, and respiratory exchange ratio during exercise in the control trial in
young and older, trained and untrained individuals
Young Old P Values
Trained (n  11) Untrained (n  10) Trained (n  8) Untrained (n  9) Age Training Intensity Interactions
V˙O2, ml/min
60 W 1,587  75 1,563 36 1,424  94 1,319 80  0.01 0.51  0.01  0.27
100 W 2,059  76 2,099 75 1,896  81 1,757 99
25 % Wmax 1,994  95 1,830 65 1,442  116 1,196 87  0.01  0.01  0.01  0.01
50 % Wmax 3,112  129 2,839 127 2,156  134* 1,785 111*
75 % Wmax 4,080  174 3,482 134 2,656  138* 2,279 131*
100 % Wmax 4,459  141 3,692 138 2,732  235* 2,429 156*
V˙CO2, ml/min
60 W 1,197  55 1,215 55 1,177  85 1,099 68 0.12 0.81  0.01  0.15
100 W 1,685  70 1,844 80 1,655  75 1,588 99
25 % Wmax 1,614  70 1,553 61 1,172  114 971 70  0.01  0.01  0.01  0.01
50 % Wmax 2,667  82 2,654 120 1,925  124* 1,615 81*
75 % Wmax 3,849  143 3,604 130 2,591  134* 2,181 101*
100 % Wmax 5,231  212 4,296 190 2,897  245* 2,550 125*
RER
60 W 0.76  0.02 0.78  0.01 0.82  0.01* 0.83 0.02*  0.01 0.04  0.01  0.01
100 W 0.82  0.02 0.88  0.02† 0.87  0.01 0.90 0.02†
25 % Wmax 0.81  0.01 0.85  0.01 0.81  0.02 0.81 0.02  0.01 0.07  0.01 0.01
50 % Wmax 0.86  0.02 0.94  0.02 0.89  0.01 0.91  0.02
75 % Wmax 0.95  0.02 1.04  0.02 0.98  0.02 0.96  0.02
100 % Wmax 1.17  0.02 1.16  0.03 1.06  0.02* 1.06  0.03*
Values are means  SE. V˙ O2, oxygen uptake; V˙ CO2, carbon dioxide production; RER, respiratory exchange ratio. Wmax, maximal workload. P values
represent ANOVA results. *P  0.05 vs. young, †P  0.05 vs. trained.
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age (P  0.01) was observed in pH, but there was no main
effect of either condition (P  0.14) or training status (P 
0.44). No main effects of condition (P 0.99) or training (P
0.23) were found for HCO3, but there was an interaction
between age and intensity (P  0.01). At exhaustion HCO3
was lower in YTUT vs. OTUT in the control trial and CO2
trial (18.2  0.9 vs. 20.7  0.3 mmol/l and 18.3  0.6 vs.
20.5  0.5 mmol/l, P  0.01).
Cerebral and vastus lateralis muscle oxygenation. Cerebral
StO2 was increased in response to supplemental CO2 whereas
muscle StO2 was unaffected (Fig. 3). Changes in cerebral and
muscle oxygenation followed a similar pattern in both age
groups; however, greater decreases in muscle oxygenation
were observed in the young group when relative exercise
intensities were compared.
DISCUSSION
In support of the study aims the major ﬁndings include: 1)
conﬁrmation of the age-associated decrease in PaCO2 and
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Relative intensities:
Age p < 0.001
Intensity p < 0.001
Condition p < 0.001
Age*Condition p = 0.040
Age*Intensity p = 0.001
Intensity*Condition p < 0.001
Relative intensities:
Age p < 0.001
Intensity p < 0.001
Condition p < 0.001
Intensity*Condition p < 0.001
† † †
††
†
*†
*
*
‡ all exercise intensities
‡ all exercise intensities
****
***
* * *
*
* *†
*†
† †
† †
‡
‡
*
*
A B
C
††
‡ all exercise intensities
D
Absolute intensities:
Age p < 0.027
Intensity p < 0.001
Condition p = 0.124
Intensity*Age p < 0.001
Age*Intensity*Condition p = 0.002
Relative intensities:
Age p = 0.383
Intensity p < 0.001
Condition p = 0.914
†
†
Fig. 1. Arterial PCO2 (PaCO2; mmHg; A), mean
middle cerebral artery velocity (MCAvmean;
cm/s; B), mean arterial pressure (MAP;
mmHg; C), and cerebrovascular conductance
(CVC; cm·s1·mmHg1; D) in young (black
symbols) and old (gray symbols) with (circles)
and without (triangles) administered CO2.
Measurements were completed at baseline
(BL) and throughout graded maximal exercise.
Wmax, maximal workload. Values are means
SE. P values represent ANOVA results. *P 0.05
vs. young, †P 0.05 vs. control trial, ‡P 0.05 vs.
baseline.
H519CEREBRAL PERFUSION, AGE, AND FITNESS
AJP-Heart Circ Physiol • doi:10.1152/ajpheart.00177.2014 • www.ajpheart.org
23
MCAvmean at rest and during exercise; 2) hypercapnic cere-
brovascular reactivity is not altered with increased age; 3) the
experimentally induced increase in PaCO2 abolished 	50% of
the age-related reduction in MCAvmean during exercise; 4)
aerobic ﬁtness in young and older humans does not inﬂuence
MCAvmean at rest or during exercise; and 5) improvements in
cerebral oxygenation by CO2 administration do not lead to
improved exercise performance in either young or older study
participants.
Inﬂuence of age on resting PaCO2 and MCAvmean. The
reduction in resting MCAvmean with age observed in the
present study is in agreement with studies assessing CBF using
transcranial Doppler ultrasonography (7, 9, 15, 32, 49), the
Kety-Schmidt technique (25), and arterial spin labeling MRI
(27). Possible mechanisms for the age-related decrease in CBF
include decreased neuronal activity (29), increased arterial
stiffness (50), reduced cerebrovascular reactivity (22), and
global brain atrophy (11), although the latter has been argued
not to contribute to the age-related decline in CBF (6). Re-
duced PaCO2 has also been associated to the age-related
decrease in MCAvmean (9) and in agreement herewith we
observed that PaCO2 and MCAvmean are both lower in the
older study participants. Others, however, have not demon-
strated such a relationship (15, 28, 32, 49), although three of
four of these studies reported that PaCO2 was 1 to 2.8 mmHg
lower in the older subjects. A possible explanation for PaCO2
to be lower with age in some humans could be secondary to
age-related metabolic acidosis (13). However, in a follow up
study the same authors reported elevated blood acidity in the
elderly, but no age-related difference in PaCO2 was reported
(14). Furthermore, in the present study resting capillary blood
pH was not reduced with age, and does hence not support an
Fig. 2. PaCO2 (mmHg; A), MCAvmean (cm/s; B), and
CVC (cm·s1·mmHg1; C) in young (left panel) and
old (right panel) trained (open symbols) and untrained
(ﬁlled symbols) subjects with (circles) and without
(triangles) CO2 administered. Values are means  SE.
P values represent ANOVA results. §P  0.05 vs.
trained.
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age-related acidosis, at least in the subjects participating in the
present study.
PaCO2 and MCAvmean during exercise in old and young
humans. In the present study PaCO2 increased gradually in the
young and older groups until an exercise intensity of 	75%
Wmax was reached, and thereafter declined in agreement with
previous work (10, 20). Although MCAvmean followed a sim-
ilar pattern, the decline, however, was less apparent. Cerebro-
vascular conductance (CVC; MCAvmean/MAP) exhibited a
diminished elevation with increasing exercise intensity and
was markedly decreased at maximal exercise (Fig. 1). This
could be indicative of MAP being the dominating force in-
creasing CBF during the early light phase of exercise (39) and
the subsequent switch to PaCO2 becoming the dominant reg-
ulator of CBF at higher exercise intensities.
Age did not inﬂuence the response pattern of MCAvmean,
PaCO2, or CVC; however, in the older group, lower
MCAvmean, PaCO2, and CVC values were observed throughout
compared with the younger participants (Fig. 1). Possible
mechanisms underlying this age effect remain unclear. To
test the importance of PaCO2 for the age-associated de-
crease in MCAvmean, young and old volunteers performed
an exercise trial with CO2 administered to the inspired air.
This approach has been used in different settings (8, 36, 44)
and proven effective in maintaining or increasing PaCO2 and
MCAvmean(36, 44). When increasing PaCO2 in the aged pop-
ulation to values similar to those observed in the young
controls (Fig. 1A), 	50% of the age-related difference in
MCAvmean was abolished (Fig. 1B), indicating that although a
major part of the reduction in MCAvmean with age is related to
the lower PaCO2, other factors are also involved. It has been
suggested that differences in PaCO2 may account for 30% of
the age-related decline in MCAvmean (1), and thus according to
the present study this may be somewhat an underestimate. As
MCAvmean and PaCO2 in young and old participants present an
age-related difference already at rest, the difference observed
during exercise could derive from here. The percentage change
in MCAvmean during exercise was similar in young and old and
in agreement with a previous study (28), although at 50%
V˙ O2peak a lower MCAvmean response was observed in the
elderly. Similarly, the percent changes from baseline in PaCO2
were comparable in young and old participants. Thus exercise
does not appear to exacerbate the age-related difference in
PaCO2 and MCAvmean manifested at rest.
As PaCO2 accounts for 	50% of the age related decrease in
MCAvmean, other factors must also contribute to the decline.
As mentioned decreased neuronal activity (29), increased ar-
terial stiffness (50) and reduced cerebrovascular reactivity (4,
22, 48) are potential contributors. Cerebrovascular reactivity,
which in the current study was assessed as hypercapnic reac-
tivity, demonstrated no difference between the two groups
when expressed as absolute and relative changes in MCAvmean,
in support of previous studies (15, 24). Unfortunately none of
these studies determined CVC reactivity. In the present study a
trend (P  0.06) toward a reduced hypercapnic reactivity was
evident. In contrast an increase in hypercapnic reactivity,
calculated as relative and CVC changes, in elderly has been
reported (49). Since no apparent explanation seems at hand for
the discrepancies, the inconsistencies in hypercapnic reactivity
results might arise from differences in the CBF measurement
techniques, CO2 stimulus, and age range of the study partici-
pants. In future studies blood pressure changes and therefore
CVC reactivity should also be taken into consideration.
Despite having a lower MCAvmean this may not necessarily
also lead to a lower brain oxygenation in the elderly, as a
reduced oxygen delivery to the brain may be compensated for
by an augmented oxygen extraction and thereby maintain
cerebral oxygenation (34). Fisher et al. (9) however demon-
strated similar cerebral oxygenations despite differences in
cerebral perfusion between young and older individuals. In the
present study brain delta oxygenation also did not differ be-
tween age groups; one limitation, however, is that we assessed
tissue oxygenation index and not absolute oxy- and deoxyhe-
moglobin values or direct arterio-venous differences.
The inﬂuence of aerobic ﬁtness on MCAvmean and hypercap-
nic reactivity. Physical activity has been suggested to maintain
MCAvmean and cerebrovascular reactivity (2, 32). In the pres-
ent study aerobic ﬁtness neither in the young nor in the old
group inﬂuenced resting MCAvmean or hypercapnic reactivity.
Recent studies (4, 49) also reported a lack of an association
between ﬁtness and MCAvmean in young vs. older individuals.
In contrast, life-long physical activity/training has shown an
attenuated age-dependent decline in resting MCAvmean (2, 3)
and CBF (2, 3, 46). When the same relative exercise intensities
were compared the trained study participants displayed a
higher PaCO2 in the control trial, and this was independent of
age. The reason could be related to the fact that trained
 d
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Fig. 3. Relative changes (delta) to baseline (BL) for cerebral (brain StO2; A)
and muscle (leg StO2; B) tissue oxygenation in response to exercise performed
with (circles) or without (triangles) administered CO2 to inspiration in young
(black symbols) and old (gray symbols) participants. Values are means  SE.
P values represent ANOVA results.
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participants were exercising at a higher absolute workload
and hence also at a higher V˙ O2 and in most instances
therefore also higher PaCO2. The elevated PaCO2 in trained
subjects did not lead to a concomitant higher MCAvmean
although trained study volunteers, especially the trained
older, had a higher MCAvmean during exercise, although not
reaching statistical signiﬁcance (P  0.16).
Several studies have investigated the inﬂuence of aerobic
ﬁtness on hypercapnic reactivity, and in agreement with our
results Zhu et. al (49) demonstrated no effect of aerobic ﬁtness
on hypercapnic reactivity. As indicated with respect to the
effects of age, the effects of aerobic exercise capacity on
hypercapnic reactivity are inconsistent and range from in-
creased (3) to decreased (46) reactivities in trained individuals.
The inﬂuence of cerebral oxygenation on exercise limi-
tations. The gradual decline in CBF with exercise intensity
above a certain threshold also reduces cerebral oxygenation.
This has been speculated to lead to centrally mediated fatigue
(17, 33). A unique feature of CO2 supplementation is that
whereas MCAvmean and cerebral oxygenation are increased,
oxygenation of the exercising skeletal muscles remains unaf-
fected by the intervention (Fig. 3), and hence the isolated
inﬂuence of altered brain oxygenation can be assessed. In the
present study a reduced decline in cerebral oxygenation did not
result in a higher exercise capacity. Our results are in line with
recent work (44, 45) and hence support that brain oxygenation
is not a parameter of importance for fatigue development
during maximal exercise. Indeed, supplemental CO2 adminis-
tered to the inspired air tended to reduce exercise performance
as the duration of the 100% Wmax step was shorter during the
CO2 trial. One potential reason for the negative inﬂuence of
CO2 administration to exercise performance is a hyperventila-
tion-induced acidiﬁcation (45, 47). Previous studies have not
assessed blood gas variables at maximal exercise when CO2
was administrated. Capillary pH was unaffected by the supple-
mental CO2 gas. CO2 induced hyperventilation could direct
blood ﬂow away from the exercising muscles and support the
additional work and metabolic demand of the respiratory mus-
cles. However, ventilation did not differ between the control
and CO2 trial.
Limitations. We assessed MCAvmean by TCD as a surrogate
for CBF. MCAvmean is a measure of blood ﬂow velocity and
not a ﬂow in absolute terms. Nevertheless the two are highly
correlated (5). The majority of studies have illustrated that the
diameter of the MCA does not change in response to hyper-
capnia (16, 38). Thus assessment of blood velocity using TCD
has been accepted as a reliable measure of CBF and is widely
used to study age and exercise-related effects (9, 10, 28, 32). In
the present study we focused on PaCO2 as it is one of the major
CBF regulators; however, whether it is PaCO2 or in fact pH, or
both, that are responsible for the hypercapnia-induced vasodi-
lation remains uncertain. Studies manipulating arterial pH,
extravascular pH, and PaCO2 proposed changes in extravascu-
lar pH to be responsible for the hypercapnia- induced vasodi-
lation (18, 26). In the present study baseline pH values did not
differ between age groups, suggesting and agreeing with the
above that capillary pH may not be the main factor responsible
for the decrease in MCAvmean in older individuals. It can,
however, not be ruled out that extravascular pH may have been
different in the two populations and thereby at least partly
involved.
Trained study volunteers were included independent of their
regimen of training conducted. This could have become a
problem since it is still debated whether resistance training
leads to increased arterial stiffness (31) or not (40). However,
since none of the subjects were predominantly engaged in
resistance training this is likely not to have inﬂuenced the study
outcome. Since only male volunteers were examined this also
implies that the obtained data may not necessarily be valid for
female although differences are not apparent (30). The PaCO2
values reported in the present study are derived from PETCO2;
however, there are studies reporting good correlations between
the two. Also in the present study the actually obtained capil-
lary blood gases correlated well with the PaCO2 estimated
from the obtained PETCO2.
Conclusion. In conclusion, reduced CBF was associated
with a lower PaCO2 at rest and during exercise in older men.
Supplemental CO2 diminished the age-related reduction in
CBF by 	50% during exercise. An elevated aerobic capacity
did not lead to increased cerebrovascular health either in our
young or in our older study participants. Finally, despite the
maintained oxygenation during the CO2 trial exercise perfor-
mance did not improve, indicating decreased cerebral oxygen-
ation not to be a limiting factor.
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Cerebrovascular reactivity is increased with acclimatization to 3 454 m altitude. 
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Abstract 
Controversy exists regarding the effect of high altitude exposure on cerebrovascular CO2 reactivity 
(CVR). Confounding factors in previous studies include the use of different experimental 
approaches, ascent profiles, duration and severity of exposure and plausibly environmental factors 
associated with altitude exposure. One aim of the present study was to determine CVR throughout 
acclimatization to high altitude when controlling for these. Middle cerebral artery mean velocity 
(MCAvmean) CVR was assessed during hyperventilation (hypocapnia) and CO2 administration 
(hypercapnia) with background normoxia [sea-level (SL)] and hypoxia (3 454 m) in nine healthy 
volunteers [26±4years (mean±SD)] at SL, and after 30 min (HA0), 3 (HA3) and 22 (HA22) days of 
high altitude (3 454 m) exposure. 
At altitude, ventilation was increased whereas MCAvmean was not altered. Hypercapnic CVR was 
decreased at HA0 (1.16±0.16%/mmHg, mean±SEM) whereas both hyper- and hypocapnic CVR 
were increased at HA3 (3.13±0.18 and 2.96±0.10%/mmHg) and HA22 (3.32±0.12 and 
3.24±0.14%/mmHg) compared with SL (1.98±0.22 and 2.38±0.10%/mmHg) (p<0.01) regardless of 
background oxygenation. Cerebrovascular conductance (MCAvmean/mean arterial pressure) CVR 
was determined to account for blood pressure changes and revealed an attenuated response. 
Collectively our results demonstrate that hypocapnic and hypercapnic CVR are both elevated with 
acclimatization to high altitude.  
Keywords: brain blood flow, cerebrovascular conductance, CO2 reactivity, hypoxia, middle 
cerebral artery, TCD 
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Introduction 
Ensuring an adequate cerebral blood flow and O2 delivery is crucial and is in normoxia largely 
regulated by the arterial partial pressure of CO2 (PACO2).1 Elevations in PACO2 (hypercapnia) lead 
to vasodilation, whereas decreases in PACO2 (hypocapnia) facilitate vasoconstriction of the 
cerebrovasculature.1 The cerebrovasculature is less sensitive to changes in the arterial O2 partial 
pressure (PAO2), with vasodilation only occurring when PAO2 declines below ~ 60 mmHg .2 With 
acute exposure to high altitude, the hypoxic vasodilatory effect facilitates an elevation in cerebral 
blood flow, however with acclimatization to altitude this is counteracted by the hypoxic ventilatory 
response which causes a reduction in PACO2 and thus cerebral blood flow declines towards sea-
level values.3, 4 Cerebrovascular CO2 reactivity (CVR), a measure of cerebrovascular function,5 
may intuitively be expected to be decreased in response to the ventilatory induced reduction in 
PACO2 in order to preserve cerebral blood flow. Yet, several studies have assessed CVR in 
response to hypoxic exposure6-15 and the outcomes are highly controversial, ranging from 
increased,7, 9, 13, 14 unchanged10, 12, 15 to reduced6, 8, 11 CVR. These differences possibly derive in part 
from inconsistencies in study protocols and methods applied. In this regard, the CVR tests have 
been conducted with background oxygen levels ranging from being hypoxic,6, 10-12 normoxic6, 10 to 
hyperoxic.7-9, 11, 13 This may influence the results as peripheral chemoreceptor sensitivity is 
increased in response to chronic hypoxia16 and in addition, the hypoxic vasodilatory effect may 
affect CVR.2 Moreover, the time points of CVR assessment in the above mentioned studies vary 
not only between studies from several minutes to 16 days at hypoxia, but also within studies where 
measurements were conducted e.g within 2 – 4 days.8 Finally, only a few studies have taken 
changes in blood pressure into account when assessing CVR,7, 9 despite the demonstrated effects of 
hypoxia, hyper- and hypocapnia on blood pressure17 and cerebral autoregulation.18, 19  Furthermore, 
most studies have been conducted under conditions similar to a mountain expedition8, 9, 11, 15 
including a trekking ascent over several days, board and lodging, which contrast markedly with 
subject’s usual environment and habits, all being potential confounding factors. 
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To overcome, at least in part, these limitations we performed a study at the Jungfraujoch research 
station (3 454 m) where living conditions are comparable to subject’s daily life and allow for 
measurements immediately after a two hour train ascent. Hypo- and hypercapnic CVR were 
assessed in background hypoxia and normoxia at sea level and then again after exactly 30 min, 3 
and 22 days of hypoxic exposure. We hypothesized that hypo- and hypercapnic CVR would be 
unaffected during acute exposure to high altitude, but would increase with acclimatization.   
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Materials and Methods 
All experimental protocols and procedures conformed to the Declaration of Helsinki and were 
approved by the Ethical committee of the Swiss Federal Institute of Technology Zurich (EK 2011-
N-51).  Prior to participation, a detailed verbal and written explanation of the study was provided, 
and written informed consent to participation was obtained from each participant.  
Nine young and healthy sea-level residents (1 female) with a mean age of 26 ± 4 years (mean ± 
SD), height of 179 ± 9 cm and weight of 75 ± 10 kg, volunteered to participate in the study. They 
were not taking any medication and had no history of cardiovascular, cerebrovascular or respiratory 
disease. Subjects refrained from sleeping at > 2 500 m within the last 3 months prior to the study. 
They were instructed to avoid caffeine, alcohol and exercise within 12 h prior to the experiments 
reported here. 
Study design 
Following a full familiarization trial of the experiment detailed below, volunteers underwent four 
experimental trials: one in Zurich, Switzerland (SL, 432 m) and three at the Jungfraujoch research 
station (3 454 m), one thirty minutes after a 2 hour ascent by train, one after 3 days (HA3) and the 
last after 22 days (HA22). Each subject travelled to the research station individually to allow 
testing at the same daytime throughout all experimental trials as well as after the same duration 
spent at high altitude. 
Hypo- and hypercapnic CVR protocol 
All experimental protocols were conducted with study volunteers in a semi supine position. A 10 
min resting period, which included 5 min baseline data collection (BL), preceded the hypo- and 
hypercapnic CVR protocol. The hypo- and hypercapnic CVR protocol included four different 
levels of end tidal partial pressure of CO2 (PETCO2) which each conducted at two different levels 
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of background oxygenation (partial pressure of inspired O2, PIO2) simulating 432 m (normoxia) 
and 3 454 m (hypoxia) in a randomized order. During the first step of the hypo- and hypercapnic 
protocol study volunteers were instructed to hyperventilate for 2 min in order to reduce PETCO2 to 
17 – 20 mmHg (HV). The second step served to normalize PETCO2 (plus0). Based on this second 
step PETCO2 was increased by 5 and 10 mmHg for the third (plus5) and fourth (plus10) step of the 
hypo- and hypercapnic protocol, respectively. The duration of each step was 3 min with the aim to 
attain at least 2 min with the desired levels of PIO2 and PETCO2. In order to reach the desired levels 
of PIO2 and PETCO2 nitrogen or oxygen and CO2 was added to inspiration (Altitrainer, SMTEC, 
Nyon, Switzerland). 
 
Experimental measures 
MCAvmean was assessed using transcranial Doppler ultrasonography (TCD, Doppler Box, DWL, 
Sipplingen, Germany) with a 2 MHz probe placed over the right temporal window, prepared with 
ultrasound gel. The probe was held in place with a headgear. Mean arterial pressure (MAP) was 
recorded continuously via finger photoplethysmography (Nexfin, BMEYE B.V, Amsterdam, 
Netherlands) and heart rate (HR) and oxygen saturation (SpO2) were assessed by a pulse oximetry 
(Nellcor Oximax N-600, Mansfield, MA, USA). MCAvmean, MAP, HR and SpO2 were sampled at 
1000 Hz and stored for offline analysis (LabChart 7 Pro v7.3.5 and Powerlab, ADInstruments, 
Bella Vista, NSW, Australia). 
By breathing through a mouthpiece with the nose occluded (Hans Rudolph, Kansas City, USA) 
respiratory parameters were measured breath-by-breath using a spirometer (Cosmed Quark b2, 
Rome, Italy).  
Capillary blood samples were obtained from the right ear lobe at BL and at the end of all steps 
during the hypo- and hypercapnic CVR protocol. PCAPO2, PCAPCO2, pH and [HCO3-] were 
measured using a blood gas analyzer (ABL800, Radiometer, Copenhagen, Denmark).  
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Cerebral tissue oxygenation (cStO2) was continuously assessed on the left and right forehead by 
near infrared spectroscopy (NIRS; Invos-5100c, Covidien, Mansfield, MA, USA).  
 
Data analysis 
Data was recorded continuously. Values are presented as means ± SEM. Data parameters were 
averaged over the last min of each step during the hypo- and hypercapnic CVR protocol. 
Cerebrovascular conductance (CVC) was calculated as MCA vmean divided by MAP.  
Hypo- and hypercapnic CVR was calculated as absolute and relative changes in MCA vmean  and 
relative changes in CVC (CVCR) divided by the change in PETCO2. 
Comparisons of values were made using a repeated two-way ANOVA with the main factor being 
time (SL, HA0, HA3 and HA22) and condition (normoxia and hypoxia). Tukey’s range test was 
applied for post hoc analysis. The Pearson product-moment correlation was used to examine the 
relationship between CVR and CVCR and bicarbonate. Statistical significance was set at p < 0.05. 
Statistical analyses were performed using SAS Enterprise Guide (4.3, SAS Institute, Inc., Cary, 
NC, USA).  
34
Results 
All nine volunteers completed the entire study protocol at SL and high altitude. 
Cardiovascular, respiratory and cerebrovascular parameters at SL, HA0, HA3 and HA22 are 
presented in Table 1. Briefly, HR, MAP and MCAvmean did not change (p > 0.25) in response to 
acute or chronic exposure to high altitude. Ventilation (VE) increased by 41 ± 7 % from SL to 
HA22 (p < 0.01) and was associated to a decline in PETCO2 by 24 ± 2 % (p < 0.01). PETO2 
decreased to 54.4 ± 1.7 mmHg (p < 0.01) in response to high altitude exposure at HA0, but 
thereafter increased with prolonged exposure to high altitude compared with HA0 (p < 0.01). 
 
Hypo- and hypercapnic CVR protocol  
Figure 1 illustrates PETCO2 and PIO2 during the hypo- and hypercapnic CVR protocols. In 
background normoxia (Figure 1A) PIO2 values were 138 ± 0.5 mmHg and in hypoxia (Figure 1B) 
94.8 ± 0.3 mmHg. During hyperventilation PETCO2 values decreased to 18.7 ± 0.1 mmHg (Figure 
1A and 1B).  
 
MCAvmean, MAP, CVC and VE during hypo- and hypercapnic CVR test 
Percent changes in hypo- and hypercapnic CVR are presented in Figure 2. CVR conducted in either 
a normoxic or hypoxic background was elevated at HA3 and HA22 compared with SL and HA0 (p 
< 0.01). Overall percent changes in hypo- and hypercapnic CVR were higher with a normoxic 
background compared with the hypoxic background (2.33 ± 0.11 vs. 2.09 ± 0.11 %/mmHg, p < 
0.01).  Similar changes were assessed as absolute changes in CVR in response to hypo- and 
hypercapnia. From SL to HA22 absolute changes in hypocapnic CVR tested in normoxia and 
hypoxia were elevated  from 1.50 ± 0.14 and 1.34 ± 0.06 cm/s/mmHg to 2.07 ± 0.17 and 1.70 ± 
0.13 cm/s/mmHg (p < 0.01), respectively. Absolute changes in CVR to hypercapnia at HA0 were 
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reduced compared with SL (0.68 ± 0.10 vs. 1.26 ± 0.15 cm/s/mmHg, p < 0.01) and thereafter 
increased (p < 0.01) compared with SL and HA0. 
MAP decreased in response to hypocapnia and increased during hypercapnia (p < 0.01, Table 2). 
CVCR values are presented in Figure 3. In response to hypocapnia CVCR was elevated following 
HA22 compared with SL independent of the background level of oxygen (p < 0.01). A trend was 
observed within the CVCR values in normoxic and hypoxic background (p = 0.07). Additionally 
there was a trend for a reduction in hypercapnic CVCR from SL to HA0 (p = 0.07). 
Ventilation during the hypercapnic CVR protocol was increased with exposure to high altitude (e.g. 
SLplus10, 24.1 ± 3.1; HA22plus10, 38.8 ± 4.4 l/min; p < 0.01) as well as with elevated PETCO2 in 
background normoxia (e.g. SLplus0, 7.1 ± 0.4; SLplus10, 24.1 ± 3.1 l/min; p < 0.01) and hypoxia (e.g. 
SLplus0, 8.4 ± 0.6; SLplus10, 19.6 ± 2.5 l/min; p < 0.01). During the hypocapnic CVR protocol 
ventilation decreased with exposure to high altitude independent of background oxygen levels (e.g. 
SLHV, 61.1 ± 7.2, HA22HV, 34.3 ± 2.6 l/min; p < 0.01).  
 
Capillary blood samples 
PCAPO2 and PCAPCO2 followed the same pattern as PETO2 and PETCO2, an initial decrease 
followed by an increase and a decline throughout the exposure to high altitude, respectively (Table 
1). Bicarbonate was decreased at HA3 and HA22 (p < 0.01, Table 1) compared with SL and HA0. 
 
CVR and bicarbonate correlations 
Hypercapnic CVR correlated with the bicarbonate values in response high altitude (p < 0.01, 
Figure 4) independent of background oxygen levels.  
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Discussion 
In this study, we determined the effect of high altitude (3 454 m) exposure on CVR in a controlled 
setting where confounding factors were minimized. Our findings extend those from previous 
studies by demonstrating (1) an initial decline in hypercapnic CVR observed 30 min after high 
altitude exposure which was followed by (2) an enhanced hypercapnic CVR at HA3 and HA22 in 
background normoxia and hypoxia. Furthermore, (3) hypocapnic CVR was increased with 
acclimatization and (4) when accounting for changes in blood pressure this led to attenuated hyper- 
and hypocapnic CVRs.  
Elevated CBF has been commonly reported within the first days at high altitude due to the 
vasodilatory effect of hypoxia.3, 8 Thereafter, CBF is reported to decrease towards baseline in 
response to the hypoxic ventilatory response causing a reduction in PETCO2 and thus leading to 
vasoconstriction.3, 4, 8 In the present study, MCAvmean did not increase following the first 30 min of 
exposure to high altitude, despite a drop in PETO2 (Table 1) below the presumed vasodilatory 
threshold.2 This is in agreement with other studies6, 11, 20 and likely related to the fact that PETO2 
was only slightly below the vasodilatory threshold while the simultaneous decline in PETCO2 
counteracted the vasodilatory effect. On the other hand, previous studies have assessed MCAvmean 
using TCD as also the case in the current study. This technique may have underestimated the 
changes in CBF given that hypoxia may increase vessel diameter.21 
Controversial results exist on the effect of high altitude exposure on cerebrovascular function. In 
the present study we observed a decreased hypercapnic CVR at HA0 followed by an increased 
hypercapnic CVR at HA3 and HA22 compared with SL. In most previous studies acute 
measurements were not feasible due to the limited accessibility to the high altitude research 
facilities. In an attempt to overcome this limitation, Fan et al.7 supplied their volunteers with 
supplemental oxygen during the 3 h ascent from 1 525 to 5 260 m. However, volunteers flew to 4 
000 m and descended to 1 525 m for 48 h before ascending to 5 260 m, and thus they were not 
assessed in strictly acute altitude conditions. Consequently, this may have led to the increased CVR 
compared with SL, which contrasts the results of the present study. In agreement with the present 
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results is the reported reduction in CVR in response to normobaric hypoxia in a controlled 
laboratory setting.6 Other studies have noted decreased CVRs but following 2 – 15 days of 
exposure to high altitude.8, 10 A proposed mechanistic explanation here fore is enhanced 
sympathetic activation. However increased sympathetic nerve activity with hypoxia is not limiting 
for further dilation of larger extracranial blood vessels.22 On the other hand, the decrease in CVR 
during acute exposure to high altitude may prevent the already elevated pH to increase even 
further, by limiting the washout of hydrogen ions.23 This would support the unchanged MCAvmean 
at HA0. With acclimatization to high altitude the increase in pH is counterbalanced by the renal 
acid-base compensation, manifested by a reduction in [HCO3-],24 which has been suggested to be 
linked to the increased CVR following 2 - 4 and 16 days sojourn at high altitude.7, 9, 14 This supports 
the results of the present study (Figure 2) together with hypercapnic CVR being correlated to 
changes in [HCO3-] with acclimatization (Figure 4).  
Studies assessing CVR have not all distinguished between hypo- and hypercapnic reactivity. The 
most recent study has estimated a  MCAvmean-CO2 slope including the hypo- and hypercapnic 
range,7 although the effect of altitude on cerebrovascular responses has been suggested to differ 
between the hypo- and hypercapnic range8, 10 as demonstrated in the current study. Fewer 
discrepancies in response to high altitude have been reported in the hypocapnic range. Increased 
hypocapnic reactivity at HA3 and HA22 in the present study is in line with previous findings.8, 9 
Background oxygen level during CVR tests is a further methodological consideration yielding 
different CVR results. In the present study normoxic and hypoxic background levels during the 
CVR tests were chosen, simulating SL and 3 454 m oxygen levels, respectively, resulting in similar 
responses to exposure to high altitude. This is in agreement with Fan et al.7 also demonstrating an 
enhanced CVR with acclimatization to high altitude, when however assessed in a hyperoxic 
background. Thus background oxygen level seems not to have an effect on CVR in response to 
exposure to high altitude. 
Changes in PETCO2 may lead to changes in blood pressure and thus affect CVR.25, 26 Additionally 
alterations in cerebral autoregulation in response to hypercapnia27 and hypoxia6, 28, 29 have been 
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reported. To overcome the potential influence of MAP we have monitored MAP (Table 2) 
continuously throughout the experiments and calculated CVCR (Figure 3) to reveal direct effects of 
changes in MAP on CVR as it has been suggested.17 In comparison to CVR, CVCR resulted in 
attenuated responses to high altitude acclimatization, decreased hypercapnic CVR at H0 and 
increased hypocapnic CVR at HA3 disappeared.  
A limitation of the study is the use of TCD to assess MCAvmean, a surrogate for CBF. MCAvmean is 
a measure of blood flow velocity and not a flow in absolute terms. Nevertheless the two have been 
shown to be highly correlated.30 The majority of studies have illustrated that the diameter of the 
MCA does not change in response to hypo- and hypercapnia.31, 32 Dilation of the MCA in hypoxic 
conditions has been demonstrated in altitudes above 5 000 m,21, 33, 34 therefore diameter changes at 
3 454 m are less likely.  
In conclusion the present study represents a controlled high altitude study and extends previous 
findings by demonstrating an elevated hypo- and hypercapnic CVR with acclimatization to high 
altitude.  
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Table1. Cardiovascular, respiratory, cerebrovascular and capillary parameters at sea level (SL), 30 min 
(HA0), 3 days (HA3) and 22 days (HA22) following ascent to altitude (3 454 m). 
SL 
3454 m 
P value 
HA0 HA3 HA22 
      HR (bpm) 69±5 75±5 71±3 70±4 0.53 
MAP (mmHg) 93.0±4.2 94.3±3.0 99.5±4.7 95.8±4.6 0.25 
VE (l/min) 9.5±0.6 10.4±0.4 11.2±0.73* 13.3±0.8* † ‡ < 0.01 
BF (1/min) 15.2±1.4 17.0±1.5 17.4±1.1 18.1±1.5 0.08 
VT (l) 0.67±0.07 0.67±0.09 0.67±0.07 0.79±0.09 0.28 
PETO2 (mmHg) 91.5±1.1 54.4±1.7* 58.0±0.8* 64.2±1.2* † ‡ < 0.01 
PETCO2 (mmHg) 39.5±0.5 37.1±0.9* 32.3±0.5* † 30.0±0.6* † ‡ < 0.01 
SpO2 (%) 97.2±0.6 88.5±1.8* 89.5±0.9* 93.1±0.5† < 0.01 
MCA vmean (cm/s) 61.2±3.4 62.0±3.9 59.5±3.7 58.2±2.9 0.68 
CVC (cm/s/mmHg) 0.67±0.05 0.67±0.05 0.61±0.05 0.62±0.04 0.14 
cStO2 (%) 75.6±2.5 64.1±2.4* 69.0±3.3* 71.9±2.1† < 0.01 
pH 7.38±0.01 7.40±0.01 7.40±0.01 7.39±0.01 0.06 
PCAPCO2 (mmHg) 38.7±0.8 36.5±1.2 32.0±0.6*† 30.8±0.6*† < 0.01 
PCAPO2 (mmHg) 72.0±1.8 50.6±1.7* 55.3±1.1* 59.8±1.1*† < 0.01 
[HCO3-] (mmol/l) 22.6±0.3 22.6±0.2 21.1±0.5*† 20.4±0.4*† < 0.01 
 
Values are mean±SEM. HR, heart rate; MAP, mean arterial pressure; VE, ventilation; BF, breathing 
frequency; VT, tidal volume; PETO2, end-tidal partial pressure of O2; PETCO2, end-tidal partial pressure of 
CO2; SpO2, oxygen saturation; MCA vmean, middle cerebral artery mean velocity; CVC, cerebrovascular 
conductance; cStO2, cerebral tissue oxygenation; PCAPCO2, capillary partial pressure of CO2; PCAPO2, 
capillary partial pressure of O2; [HCO3-], bicarbonate concentration. P values represent ANOVA results. * 
P < 0.05 vs SL. † p < 0.05 vs HA0. ‡ p < 0.05 vs HA3. 
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Titles and legends to figures 
Figure 1. End tidal partial pressure of CO2 (PETCO2, dashed lines) and inspired partial pressure of 
O2 (PIO2; solid lines) during hyperventilation (HV), no additional CO2 (plus0), plus 5 mmHg CO2 
(plus5) and plus 10 mmHg CO2 (plus10) are presented in near sea level (A) and 3 454 m (B) 
conditions conducted at sea level (circle), 30 min (square), 3 days (diamond) and 22 days (triangle) 
after ascent to high altitude. 
Figure 2. Individual (grey) and mean (black) MCAvmean percent change cerebrovascular CO2 
reactivity (CVR) in response to hypocapnic (A,C) and hypercapnia (B,D) in background normoxia 
(A,B) and hypoxia (C,D) at sea level (SL), 30 min (HA0), 3 days (HA3) and 22 days (HA22) after 
ascent to high altitude . P values represent ANOVA results. * p < 0.05 vs SL. † p < 0.05 vs HA0. 
Figure 3. Individual (grey) and mean (black) cerebrovascular conductance percent change 
cerebrovascular CO2 reactivity (CVCR) in response to hypocapnic (A,C) and hypercapnia (B,D) in 
background normoxia (A,B) and hypoxia (C,D) at sea level (SL), 30 min (HA0), 3 days (HA3) and 
22 days (HA22) after ascent to high altitude. P values represent ANOVA results. * p < 0.05 vs SL. 
† p < 0.05 vs HA0. 
Figure 4. Relation between hypercpanic MCAvmean cerebrovascular CO2 reactivity (CVR) (A, B) 
and cerebrovascular conductance CO2 reactivity (CVCR) (C, D) percent changes and bicarbonate 
in background normoxia (A, C) and hypoxia (B, D) at sea level (black circles), 30 min (dark gray 
squares), 3 days (gray diamonds) and 22 days (white triangles) upon ascent to high altitude.  
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4. Conclusion and outlook
The purpose of the present PhD project was to 1) elucidate the role of CO2 on the regulation of 
CBF during exercise with aging. To better understand alterations in CBF due to changes in CO2 
with aging and during exercise, CO2 was added to inspiration during exercise in young and older 
volunteers; and 2) to study the influence of high altitude on CVR. For this purpose, hypercapnic 
and hypocapnic CVR were assessed in young and healthy volunteers during acute and prolonged 
exposure to high altitude. 
As the results obtained in each study are discussed in detail in the included manuscripts, this 
section summarizes the key points and highlights future directions for research within the 
corresponding fields. 
4.1 Age, aerobic fitness, and cerebral perfusion during exercise: Role of carbon 
dioxide 
CBF is attenuated with increasing age, both at rest and during exercise (Kety 1956; Ainslie et al. 
2008; Fisher et al. 2012) and concomitantly lower PaCO2 values have been observed in elderly 
(Fisher et al. 2012). Cerebrovascular function has also been demonstrated to be reduced in elderly 
(Ito et al. 2002; Flück et al. 2014). To investigate the underlying mechanisms of the age-associated 
reduction in CBF, CVR was assessed in young and older study volunteers and supplemental CO2 
was administered to the inspiration during exercise to examine the influence of the age-dependent 
reduction in PaCO2. Additional aims included investigating the effect of aerobic fitness on the 
decline in CBF with aging and examining whether decreased CBF and thus cerebral oxygenation at 
maximal exercise limits exercise performance.  
In agreement with previous studies (Kety 1956; Ainslie et al. 2008; Fisher et al. 2012) CBF was 
reduced at rest and during exercise with aging. CVR was however not reduced in the present study, 
and hence seems not to contribute to the age-related reduction in CBF. In contrast, administration 
of CO2 to inspiration during exercise abolished the age-related decrease in CBF by ≈ 50 % and thus 
the observed reduction in PaCO2 with age seems to explain most of the reduction in CBF. 
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Previously, aerobic fitness has been associated with a diminished decline in CBF with increasing 
age (Ainslie et al. 2008). However, higher aerobic capacity in our young and older study 
participants did not lead to improved CVR. Finally, although the drop in CBF with increasing 
exercise intensity was prevented by adding CO2 to inspiration and thus maintained cerebral 
oxygenation, this however did not lead to an increased exercise performance. Thus, indicating 
decreased cerebral oxygenation not to be a limiting factor for exercise performance. 
4.2 Cerebrovascular reactivity increases with acclimatization to 3454 m 
Controversy exists regarding the effect of high altitude exposure on CVR, as increases, decreases 
or no changes have been observed. Confounding factors in previous studies include the use of 
different experimental approaches, ascent profiles, duration and severity of exposure and plausibly 
environmental factors associated with altitude exposure. The aim of the present study was to 
determine hypercapnic and hypocapnic in response to acute and throughout acclimatization to high 
altitude when controlling for these. 
At the Jungfraujoch research station (3454 m), where confounding factors are minimized, 
hypercapnia and hypocapnic CVR were assessed in background normoxia and hypoxia. Our data 
extend those from previous studies by demonstrating an initial decline in hypercapnic CVR 
observed after 30 min of high altitude exposure, which was followed by an enhanced hypercapnic 
CVR after 3 and 22 days at high altitude independent of background oxygenation. Furthermore, 
hypocapnic CVR was increased with acclimatization. Accounting for changes in blood pressure led 
to attenuated hyper- and hypocapnic CVRs. This underlines the importance of controlling for 
confounding factors. Overall, the cerebrovasculature maintains or even improves its reactivity in 
response to prolonged exposure to high altitude, however, whether this is beneficial for altitude 
acclimatization needs further investigation. 
4.3 Outlook 
As reduced brain perfusion is associated with cognitive impairment and brain damage, it is of 
general interest to prevent the decline in CBF with increasing age. The present PhD project 
revealed a decreased PaCO2 to be partly responsible for the age-related decline in CBF during 
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exercise. The origin of the observed hypocapnia at rest and during exercise in the older individuals 
is unknown. A reduced CO2 production, hyperventilation, decreased pulmonary perfusion, 
metabolic acidosis (Frassetto and Sebastian 1996; Laffey and Kavanagh 2002) are all possible 
mechanisms leading to hypocapnia. Hyperventilation, however, can be ruled out in the 
present study, as ventilation did not differ between young and old individuals. Further 
investigations are needed to elucidate the underlying mechanisms of hypocapnia in older 
individuals and its effect on the cerebrovasculature. Secondly, CBF underlies an integrative 
regulation and besides PaCO2 being a major regulator of CBF other factors contribute to the 
regulation of CBF. Additional research is required to fully understand age-associated effects on 
CBF during exercise. Sympathetic nerve activity, cerebral autoregulation and cerebrovascular 
health may all play a role. A possible way to investigate the influence of sympathetic nerve 
activity on the age-related reduction in CBF during exercise is to specifically inhibit the 
sympathetic nervous system. 
Increased cerebrovascular reactivity is associated with increased cerebrovascular health. In the 
present PhD project an elevated cerebrovascular reactivity to hyper- and hypocapnia was observed 
with acclimatization to high altitude. Intuitively, this would mean an increased cerebrovascular 
health and therefore this may serve to maintain precise regulation of CBF in this environment. On 
the other hand, as PaCO2 decreases with exposure to high altitude and hypocapnic reactivity has 
been shown to be increased this leads to a proportionally greater reduction in cerebral perfusion. 
Whether an increased reactivity to hyper- and hypocapnia of the cerebrovasculature at altitude 
benefits or even prevents high altitude sickness remains to be further investigated. 
 Furthermore, underlying mechanisms leading to altered CVR in response to acute and chronic 
exposure to high altitude are still uncertain. Administration of bicarbonate during altitude exposure 
could clarify the role of acid-base compensation on the increase in hypercapnic CVR. Additionally, 
as PaCO2 is decreased in response to high altitude exposure and further reduced by the hypoxic 
ventilatory response, a different stimulus might reveal less biased information on the reactivity of 
the cerebrovasculature at high altitude. This could e.g. be a flashing checkerboard (visual 
52
stimulation), which affects blood flow to the visual cortex and thus regional cerebrovascular 
reactivity could be assessed in the posterior cerebral artery. 
 
In addition, technological advances allow measurement of CBF with a higher accuracy by 
measuring internal carotid and vertebral arteries volumetrically using linear-array vascular 
ultrasound. Additionally, transcranial color coded duplex technology enables to assess changes in 
diameter of the MCA (Willie et al. 2012; Willie et al. 2014) and thus overcomes the flow versus 
velocity limitation. 
 
From a personal point of view, I have been fortunate to receive support from the Swiss National 
Science Foundation to join Prof. Dr. Philip Ainslie’s laboratory at the University of British 
Columbia, Kelowna, Canada for a post doc fellowship. This enables me to not only acquire the new 
techniques within the field but also to further elucidate the regulation of CBF and its underlying 
mechanisms. Specifically, I will focus on sympathetic nerve activity and cerebral metabolism and 
their role in the regulation of CBF in response to changes in MAP. 
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